Dear readers,
This quiz consists of actual questions from
various Banking entrance exams held during the last few years. Leave your
answers/ responses in the comments section below and soon we’ll let you know the
correct answers!
Directions (Q.1-5) In each of the
following questions two rows of numbers are given. The resultant number in each
row is to be worked out separately based on the following rules and the
questions below the rows of numbers are to be answered. The operations of
numbers progress from left to right.
Rules :
(i) If a
two digit odd number is followed by a two digit odd number they are to be
added. (ii) If a two digit even number is followed by a two digit odd number
which is the perfect square, the
even number is to be subtracted from the odd number.
(iii) If a
three digit number is followed by a two digit number the first number is to be divided
by the second number.
(iv) If a
prime number is followed by an even number the two are to be added.
(v) If an
even number is followed by another even number the two are to be multiplied.
1.
37 12 21
38 81 14
What is the difference between the
resultants of the two rows?
(1)
23 (2) 32 (3) 13 (4) 18 (5) None of these
2.
23 15 12
X 24 49
If X is the resultant of the first
row, what is the resultant of the second row?
(1)
24 (2) 25 (3) 28 (4) 22 (5) None of these
3.
16 8 32
132 11
X^2
If X is the resultant of the first
row, what is the resultant of the second row ?
(1)
192 (2)
128 (3) 132
(4) 144 (5) None of these
4.
345 23
X
45 17
81
If X is the resultant of the second
row, what is the resultant of the first row?
(1)
285 (2) 33 (3) 135 (4) 34 (5) None of these
5.
12 28
84
37 22 18
What is the sum of the resultants
of the two rows?
(1)
77 (2) 87 (3) 84 (4) 72 (5) None of these
Directions (Q.6-10) Below is given
a passage followed by several possible inferences which can be drawn from the
facts stated in the passage. You have to examine each inference separately in
the context of the passage and decide upon its degree of truth or falsity.
Mark answer (1) if the inference is
‘definitely true’, i.e., it properly follows from the statement of facts given.
Mark answer (2) if the inference is
‘probably true’ though not ‘definitely true’ in the light of the facts given.
Mark answer (3) if the ‘data are
inadequate’, i.e., from the facts given you cannot say whether the inference is likely to
be true or false.
Mark answer (4) if the inference is
‘probably false’, though not ‘definitely false’ in the light of the facts given.
Mark answer (5) if the inference is
‘definitely false’, i.e., it cannot possibly be drawn from the facts given or it contradicts
the given facts.
Growth through acquisitions and alliances has become a
critical part of creating value for pharma and biotech manufacturers and their
shareholders. However, companies and their investors may risk value destruction
if they acquire rights to a drug that suddenly poses unanticipated safety risks
for patients. Similarly, safety related compliance violations committed by an
acquired company could significantly impair the ultimate value of the
transaction and the reputation of the acquirer. The pace of deal making between
pharma and biotech companies continued to accelerate in 2006, increasing 17% to
about $18 billion. Pharma companies were typically the buyers, and the premiums
they paid increased substantially as competition intensified, to secure access
to novel drugs and biologics. The stakes increase everyday as competition
pushes up prices and drives deal-making to earlier development stages with
greater uncertainty and less time to complete through due diligence.
6.
Acquisitions of biotech companies was preferred among pharmaceutical companies
in the recent past.
7. Biotech
companies are not capable to acquire pharmaceutical companies.
8.
Pharmaceutical companies at times may incur loss after acquisition of biotech companies.
9. Safety
related issues are prime concerns for the pharmaceutical companies while negotiating
acquisition of biotech companies.
10. Stiff
competitions among the prospective buyers have resulted into erosion of value
of
the biotech
companies.
To follow our
Banking portal on Facebook and Twitter, click on the following links:
Facebook: https://www.facebook.com/pagalguybankpo
Twitter: https://twitter.com/PaGaLGuYBankPO
Answers:
1(3) 2(5) 3(1) 4(4) 5(5) 6(1)
7(3) 8(2) 9(5)
10 (4)